There are currently 223 clinical trials in Augusta, Georgia looking for participants to engage in research studies. Trials are conducted at various facilities, including Augusta University, Augusta University Medical Center, Medical College of Georgia and Georgia Regents University. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Lead Migration During the Spinal Cord Stimulation Trial Period and Therapeutic Response
NCT05956548
Recruiting
The goal of this clinical trial is to compare lead migration distance and therapeutic response for participants receiving a spinal cord stimulator during the trial period. Of note- scs trial period is a procedure name, not to be confused with this clinical trial study. The main question\[s\] it aims to answer are: * Is there a difference in migration distance and/or rate for those with external leads secured by an anchor device versus and anchor device with suture? * How does participant activ... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/13/2023
Locations: Augusta University Health System Pain Clinic, Augusta, Georgia
Conditions: Spinal Cord Stimulator Trial Period, Neuromodulation Trial Period, SCS Trial Period
Register for Updates
Endovascular Embolization for Chronic Subdural Hematomas Following Surgical Evacuation
NCT04272996
Recruiting
This study is designed to evaluate the effectiveness of endovascular embolization of middle meningeal artery following evacuation of subdural hematomas (SDHs) to assess rate of recurrence. The historical standard for treatment of subdural hematomas has been surgical evacuation through burr holes or craniotomies. Many of these patients are elderly patients who are high risk surgical candidates. A major concern is SDH recurrence. Recurrences require frequent imaging, and will lead to increased le... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
06/14/2023
Locations: Augusta University, Augusta, Georgia
Conditions: Chronic SDH and the Efficacy of Embolization
Register for Updates
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
NCT05881564
Recruiting
To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.
Gender:
ALL
Ages:
All
Trial Updated:
05/30/2023
Locations: Children's Hospital of Georgia, Augusta, Georgia
Conditions: Congenital Heart Disease
Register for Updates
Firdapse for Post-BOTOX Vocal Weakness
NCT05123053
Recruiting
Botox injections into the thyroarytenoid muscle are a predictable and effective treatment for SD, but typically result in transient symptoms of voice weakness and breathiness during the first 2-3 weeks after injection. Investigators hypothesize that voice weakness and breathiness after Botox treatment can be alleviated using amifampridine.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/24/2023
Locations: Augusta University, Augusta, Georgia
Conditions: Vocal Weakness(Post-BOTOX Injection)
Register for Updates
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
NCT05771597
Recruiting
Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority of patients in the community, and is not covered by many insurance companies. The purpose of this study is to 1. Evaluate home biofeedback therapy for patients with either constipation and dyssynerg... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/14/2023
Locations: Augusta University, Augusta, Georgia
Conditions: Fecal Incontinence, Dyssynergic Defecation, Urinary Incontinence
Register for Updates
KRT-232 and TKI Study in Chronic Myeloid Leukemia
NCT04835584
Recruiting
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to a Tyrosine Kinase Inhibitor (TKI). This study is a global, open label Phase 1b/2 to determine the efficacy and safety of KRT-232 in patients with chronic phase CML (CML-CP) and accelerated phase (CML-AP) who have failed TKI treatments.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/04/2022
Locations: Georgia Cancer Center at Augusta University, Augusta, Georgia
Conditions: Chronic Myeloid Leukemia
Register for Updates
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442
Recruiting
This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to wound bed preparedness through 6 weeks (Part A) and wound site healing, graft take and long-term scar outcomes (Part B). Subjects will be treated with both control and microsurfaced cadaveric grafts... Read More
Gender:
ALL
Ages:
21 years and above
Trial Updated:
01/13/2021
Locations: Joseph M Still Research Foundation, Augusta, Georgia
Conditions: Burns, Wound Heal
Register for Updates